![Leading on the Edge of Chaos: The 10 Critical Elements for Success in Volatile Times [BARGAIN PRICE]](http://images.amazon.com/images/P/B00008NRH5.01.MZZZZZZZ.jpg)
![Reengineering the Corporation [DOWNLOAD: ADOBE READER]](http://images.amazon.com/images/P/B000088UYF.01.MZZZZZZZ.jpg)
![High Tech Start Up, Revised and Updated: The Complete Handbook for Creating Successful New High Tech Companies [DOWNLOAD: ADOBE READER]](http://images.amazon.com/images/P/B00005ARYD.01.MZZZZZZZ.jpg)
Average customer rating: 
|
Drugs to Market (Technology, Innovation, Entrepreneurship and Competitive Strategy)
W.C. Bogner , and H. Thomas Manufacturer: Pergamon ProductGroup: Book Binding: Hardcover  Strategy & Competition
| Management & Leadership
| Business & Investing
| Subjects
| Books
Production & Operations
| Management & Leadership
| Business & Investing
| Subjects
| Books
Economics
| Business & Investing
| Subjects
| Books
| Agricultural
| Commercial Policy
| Comparative
| Consolidation & Merger
| Cooperatives
| Debt & Deficits
| Development & Growth
| Econometrics
| Economic Conditions
| Economic History
| Economic Policy & Development
| Exports & Imports
| Free Enterprise
| Inflation
| International
| Labor & Industrial Relations
| Macroeconomics
| Microeconomics
| Money & Monetary Policy
| Natural Resources
| Privatization
| Public Finance
| Statistics
| Sustainable Development
| Theory
| Unemployment
| Urban & Regional
General
| Popular Economics
| Business & Investing
| Subjects
| Books
General
| Business & Investing
| Subjects
| Books
Advertising
| Marketing & Sales
| Business & Investing
| Subjects
| Books
General
| Industries & Professions
| Business & Investing
| Subjects
| Books
History of Science
| History & Philosophy
| Science
| Subjects
| Books
Pharmacy
| Pharmacology
| Medical
| Professional & Technical
| Subjects
| Books
All Amazon Upgrade
| Amazon Upgrade
| Stores
| Books
Business & Investing
| Amazon Upgrade
| Stores
| Books
Professional & Technical
| Amazon Upgrade
| Stores
| Books
Science
| Amazon Upgrade
| Stores
| Books
ASIN: 0080425593 |
Book Description
The development and marketing of drugs since the Second World War offers an exemplary demonstration of the impact of technology on competitiveness in a major industry. While focusing primarily on the market in the USA, this study examines also the activities of European firms, their contribution to the industry's technological evolution and the impact of their entry into the US market.The main concern of the book, however, is to examine all the elements which go to make up the evolving landscape of competition, and their interaction. Thus, the effects of technological change are viewed in the context of changes in the legal and regulatory environment, and in competitive practice. For both the market as a whole and the individual firm this analysis illustrates how competitive positions actually emerge as a result of such interactions.
Consistent with this wider view, both the technological and the non-technological competencies of firms are discussed, and the concept of core competence is used extensively to show how individual firms developed and maintained their competitive strengths, as the industry moved from deep-tank fermentation through to the first decade of biotechnology. The final chapter highlights the key role of biotechnology in shaping the future of the industry, at a time of increased regulation and accelerating market driven change.
Customer Reviews:
A needed but disappointing book.......1999-10-15
The final two chapters are entitled: 6) Firm responses in a changing industry, 7) Forces in competition: past, present and future. The sixth chapter is awful, here the authors, both of them management researchers from different business colleges (neither with a background in science or medicine) analyzed nearly 20 years of inadequate data in a ridiculous way that was poorly presented. The seventh and final chapter was also disappointing. Someone should take the good material in this book as a template and write another book, especially in speculating about the future impact of biotechnology on the pharmaceutical industry. If I were you, I would get a good book on the history of the pharmaceutical industry, and make your own inferences about competitive forces.
Average customer rating: 
|
Competitive Strategies in the Pharmaceutical Industry
Manufacturer: American Enterprise Institute Press ProductGroup: Book Binding: Hardcover Strategy & Competition
| Management & Leadership
| Business & Investing
| Subjects
| Books
Production & Operations
| Management & Leadership
| Business & Investing
| Subjects
| Books
Economics
| Business & Investing
| Subjects
| Books
| Agricultural
| Commercial Policy
| Comparative
| Consolidation & Merger
| Cooperatives
| Debt & Deficits
| Development & Growth
| Econometrics
| Economic Conditions
| Economic History
| Economic Policy & Development
| Exports & Imports
| Free Enterprise
| Inflation
| International
| Labor & Industrial Relations
| Macroeconomics
| Microeconomics
| Money & Monetary Policy
| Natural Resources
| Privatization
| Public Finance
| Statistics
| Sustainable Development
| Theory
| Unemployment
| Urban & Regional
General
| Popular Economics
| Business & Investing
| Subjects
| Books
General
| Business & Investing
| Subjects
| Books
General
| Industries & Professions
| Business & Investing
| Subjects
| Books
Pharmacy
| Pharmacology
| Medical
| Professional & Technical
| Subjects
| Books
ASIN: 0844738824 |
Book Description
The authors explore pricing of pharmaceutical products in both domestic and international markets, forces affecting competition in world markets, and how competition affects risks and returns to research and development. Index.Books: